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Abstract
Background:  Why waiting lists arise and how to address them remains unclear, and an improved
understanding of these waiting list "dynamics" could lead to better management. The purpose of
this study is to understand how the current shortage in radiation therapy in Ontario developed;
the implications of prolonged waits; who is held accountable for managing such delays; and short,
intermediate, and long-term solutions.
Methods:  A case  s tudy  of t he  rad iat ion the rapy shortage  in 1998-99 at Prince ss Margare t
Hospital, Toronto, Ontario, Canada. Relevant documents were collected; semi-structured, face-to-
face interviews with ten administrators, health care workers, and patients were conducted, audio-
taped and transcribed; and relevant meetings were observed.
Results:  The radiation therapy shortage arose from a complex interplay of factors including: rising
cancer incidence rates; broadening indications for radiation therapy; human resources management
issues; government funding decisions; and responsiveness to previous planning recommendations.
Implications of delays include poorer cancer control rates; patient suffering; and strained doctor-
patient relationships. An incompatible relationship exists between moral responsibility, borne by
government, and legal liability, borne by physicians. Short-term solutions include re-referral to
centers with available resources; long-term solutions include training and recruiting health care
workers, improving workload standards, increasing compensation, and making changes to the
funding formula.
Conclusion:  Human resource planning plays a critical role in the causes and solutions of waiting
lists.  Waiting  lists  have  harsh  implications  for  patients.  Accountability  relationships  require
realignment.
Introduction
In early 1999 waiting lists for radiation therapy in On-
tario reached a crisis point. Newspaper articles described
the waiting lists as "agonizingly long" and "medically"
unacceptable [1], cited possible explanations of why they
developed ("Cancer experts 'ignored' over waiting lists"
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[2]), and possible solutions ("U.S. cities to treat Ontario's
cancer victims") [3].
Defined as "a roster of patients awaiting a particular
service," [4] waiting lists are a feature of public health
systems like those in the United Kingdom, New Zealand
and Canada. For example, waiting times for cancer treat-
ment in England were recently described [5]. Outstand-
ing initiatives, such as those of Naylor and Hadorn, have
focused on use of clinical data in managing waiting lists
[6,7]. However, why waiting lists arise and how to ad-
dress them remains unclear, and an improved under-
standing of these waiting list "dynamics" could lead to
better management [4]. Waiting lists are also an issue in
health care ethics since they relate to the underlying eth-
ical principle of justice.
The waiting list for radiation therapy in Toronto is a good
model in which to explore waiting list "dynamics." Evi-
dence for improved clinical outcomes including survival,
organ preservation, and quality of life with radiation
treatment is available for many tumor sites [8,9,10]. On-
cologists in Ontario are actively involved in an evidence-
based practice guideline initiative [11] that provides up
to date systematic reviews on the specific cancer treat-
ment recommendations. These practice guidelines are
widely available [12] and influence practice. A goal of
treating 45% of all incident cases of cancer was adopted
in Ontario [13]; although radiation therapy utilization
rates in Toronto were found to be significantly lower
[14].
We studied the waiting list for radiation therapy at a ma-
jor Canadian cancer center. Our objectives were to un-
derstand the "dynamics" of the waiting list - how the
current radiation therapy shortage developed; the impli-
cations of prolonged waits to receive radiation therapy;
who is held accountable for managing such delays; and
short, intermediate, and long-term solutions.
Methods
Design
We used the case study method, which "investigates a
contemporary phenomenon within its real-life con-
text."[15] The case is the radiation therapy shortage in
1998/99 at Princess Margaret Hospital (PMH), Toronto.
PMH is one of nine institutions that deliver radiation
therapy in Ontario and is Canada's largest center for can-
cer treatment, research, and education.
Data Collection
Data were collected from documents, interviews and ob-
servations of meetings, which were identified using the-
oretical sampling. Theoretical sampling is "sampling on
the basis of emerging concepts."[16] For example, if a
particular person were mentioned as influential in an as-
pect of waiting lists, we sought to interview that per-
son.[17] Documents included current memos, articles,
reports including those referred to by participants in the
context of interviews or meetings, and the agenda of rel-
evant meetings. Face-to-face interviews were conducted,
using a semi-structured interview guide based on the re-
search questions, audiotaped and transcribed with 10 in-
dividuals including two physicians, one radiation
therapist, four senior administrators (from radiation
therapy, physics, radiation oncology and a senior admin-
istrator at CCO), and three patients awaiting radiothera-
py. The 10 people selected were felt to be knowledgeable
about the current situation through first-hand experi-
ence. Of the three patients interviewed, one had breast
and the other prostate cancer, which represented the two
most prevalent types of cancer on the waiting list. Six rel-
evant meetings were observed during which detailed
'field notes' were made.
Data Analysis
These data sources generated more than 500 pages of
data that were analyzed using a modified thematic anal-
ysis. Data segments that pertained to the study objectives
were identified and coded. Coded units were compared
for similarities and differences. Related issues were
grouped into common themes (e.g. "human resource
planning", "inadequate salary", "job dissatisfaction", "re-
structuring") and then under larger domain labels (e.g.
"why waiting lists arose"). The data were then recoded
using the domain labels. This process was conducted by
one analyst (D.P.D.) in consultation with a second ana-
lyst (D.K.M.). To address validity, we conducted a "mem-
ber check" by giving a draft of this paper to three
interview participants for review and correction.
Research Ethics
The study was approved by University of Toronto Com-
mittee on Research with Human Subjects. Written con-
sent was obtained from interview participants and
individual participants are not identified.
Results
In 1998, over 6,000 new patients were seen in consulta-
tion in the Department of Radiation Oncology at PMH,
representing a 16% increase over 1997. In February 1999,
the time from referral to consultation was as much as
seven weeks. The time from deciding to administer a
course of radiation to starting curative treatment was 24-
63 days. Delays of more than two weeks from referral to
consultation or consultation to starting treatment, in-
creased from 80% of cases in October 1998 to 88% in
February 1999. These delays exceed the recommenda-
tions of the Canadian Association of Radiation Oncolo-
gists (maximum two weeks from referral to consultationBMC Health Services Research (2001) 1:3 http://www.biomedcentral.com/1472-6963/1/3
with a radiation oncologist, and two weeks from consul-
tation to start of radiation).[18] The number of patients
with various tumor sites who were waiting to start radia-
tion treatment in February 1999 is shown in Table 1. Al-
most two-thirds of the waiting patients had breast or
genito-urinary tumors for which there is good evidence
for the role of radiation therapy in improving outcomes
[9,19,20,21].
How the current radiation therapy shortage developed
The radiation therapy shortage developed as a result of
several factors. First, the incidence of cancer continues to
rise by 4% per year. Many types of cancer, like prostate
cancer, increase with age and are becoming more com-
mon with an aging population.
Second, there is greater use of radiation for certain tu-
mors such as ductal carcinoma in -situ (DCIS) of the
breast and longer courses of radiation have shown im-
proved relapse-free rates for prostate cancer [20,21, 22].
The increased utilization is reflected by an 86% increase
in the number of curative courses of radiation in Ontario
over a 10-year period [23].
Third, human resource shortages involving radiation
therapists, medical physicists, and radiation oncologists
developed. Radiation therapists' salaries are lower in
Ontario than in some other areas in Canada and the U.S.
A worldwide shortage of radiation therapists has lead to
recruitment by other centers. Training positions have
been decreased and the provincial radiation therapy
training program was closed for one year (1997). A lack
of employment prospects lead to declining numbers of
Canadian radiation oncology residents.
Finally, the Ministry of Health was slow to respond to
funding requests for additional staff and equipment.
This has limited treatment capacity and prevented hiring
of staff. Funding to operate cancer treatment facilities
have not accounted for changes in indirect services (e.g.
support staff), depreciation of equipment, or increased
numbers of patients. During prolonged waits for radia-
tion treatment in 1989, PMH closed its doors to new pa-
tient referrals, and many were sent to other Canadian
centers. In 1991, the Cancer Manpower Committee, ap-
pointed by the Ministry of Health, issued a report with
recommendations regarding human resource issues
[24]. Participants felt the current situation was a "fright-
ening replay" of the previous delays, and that prior rec-
ommendations had not been followed.
Implications of waiting lists
Participants identified three main implications of the
waiting list. First, local control of the cancer may become
compromised, with increased toxicity of treatment (e.g.
larger fields) or lower rates of organ preservation (e.g.
larynx).
Second, the psychological effect on patients waiting to
start radiation can be devastating - as one participant
commented, "soul-destroying." Patients feel powerless
about their situation: one patient interviewed reported
his cancer visibly enlarging while he waited to start treat-
ment. Prolongation of symptoms can lead to unneces-
sary suffering or requires interventions that have
adverse effects. Daily activities and work can be disrupt-
ed. One participant felt unable to "move on to the next
step in her life" while she waited.
Finally, radiation oncologists interviewed felt the pa-
tient-physician relationship was strained. The implicit
trust that the physician is providing optimal care for the
patient was lost. A heavier workload resulted in less time
spent with patients.
Accountability for waiting lists
Participants felt that government and administrators of
cancer services should be accountable for waiting lists.
However, the physician may be legally liable. Hospital le-
gal counsel advised radiation oncologists that they were
responsible for patient outcomes on waiting lists. The
Canadian Medical Protective Association, in response to
Table 1: Number of Patients Waiting to Start Treatment Radia-
tion Medicine Program - PMH on February 5, 1999
Site Group Number of 
Patients
Number of 
Patients
Radical Palliative
Breast 115 4
Central Nervous System 7 1
Endocrine 12
Head & Neck 28 0
Eye 0 1
Gastrointestinal 30 8
Genito-urinary 77 5
Gynaecological 12 2
Lung 15 15
Lymphoma 20 2
Myeloma 0 1
Paediatric 3 0
Sarcoma 7 0
Skin 12
Unknown 10
TOTALS 317 44
Radical - given with intent to provide eradication of tumor, a high 
quality of life and prolongation of survival Palliative - given to control 
or prevent symptoms of diseaseBMC Health Services Research (2001) 1:3 http://www.biomedcentral.com/1472-6963/1/3
a letter written by a concerned physician, advised that
"sound medical judgement within the accepted stand-
ards of practice for similar communities must always
guide the physician's treatment and care of patients and
take priority over cost restraints." In response to a pa-
tient's letter on delays to starting radiation, a Ministry of
Health official indicated that responsibility for timeli-
ness of treatment rests with the individual physician.
While no action has been taken against a radiation oncol-
ogist for delayed treatment, in a mock legal case involv-
ing the cardiac surgery waiting list, a judge concluded
that the physician was liable and the government was not
[25].
Short- and long-term solutions
In March 1999, the Task Force on Human Resources for
Radiation Services concluded that the current situation
could not be addressed by "quick fixes." Recommenda-
tions were made on improving training programs, re-
cruiting out-of-province workers, improving workload
standards, adding staff, increasing salary, ensuring
greater availability of continuing education and academ-
ic programs, and changing the funding formula to a per
case basis. The Minister of Health accepted these recom-
mendations [26]. With respect to short-term solutions,
participants endorsed re-referral of patients to other fa-
cilities, likely in the United States since there are waiting
lists for radiation therapy in most Ontario radiation
treatment centers [27]. The re-referral process was post-
poned several times pending a final detailed analysis of
radiation capacity in Ontario. Many logistical issues
arose from sending patients out of province for treat-
ment, including criteria for patients sent, resources re-
quired to assess patients for re-referral, follow-up care,
and legal liability.
Discussion
Although we did not conduct a detailed analysis of clini-
cal outcomes of patients on the waiting list, our study de-
scribes the "dynamics" of an actual waiting list. The
findings underscore the unexamined and unintended
moral implications of administrative decisions.
The waiting list for radiation therapy arose from an in-
terplay of factors, including: rising cancer incidence
rates; increasing indications for radiation therapy; hu-
man resource management, training and planning; gov-
ernment funding decisions; and responsiveness to
previous planning recommendations. Models proposed
to assess waiting lists for radiation do not allow for the
complexities identified in our case study [28,29,30]. The
importance of human resource management, planning
and training issues in this case study was striking.
The implications of delays for radiation include per-
ceived lower cancer control rates, patient suffering, and
strained patient-doctor relationships. While the emo-
tional consequences for patients of delays in diagnosis
and treatment may be acknowledged by the media, the
moral dimensions of this emotional burden are rarely ac-
knowledged in policy making. Current delays, and the
burdens they impose on patients, are ethically unjustifi-
able.
An incompatible relationship exists between moral and
legal responsibility - government is viewed as morally re-
sponsible but physicians may bear legal liability. Physi-
cians are given the responsibility without power to
change the waiting list situation. Although liability can
likely be reduced through disclosure of waiting times and
alternatives such as treatment elsewhere, this responsi-
bility paradox is morally untenable. Physicians ought not
to be held liable for administering treatment schedules
that are beyond their control. Moral and legal accounta-
bilities for waiting lists require realignment.
A short-term solution is re-referral, although this
presents logistical difficulties. Increased "supply" of hu-
man resources cannot necessarily be rectified quickly by
an infusion of money, and delayed corrective action may
never solve a growing problem [31]. This may explain the
mixed results of increasing resources to ameliorate wait-
ing lists. A sustained commitment to human resource
planning is required.
Our study has four main limitations. First, it focussed on
waiting list "dynamics" rather than clinical outcomes.
Second, it examined waiting lists at a single radiation
treatment center and may not be generalizable.. Howev-
er, some of the findings, such as the importance of hu-
man resource management, will likely be generalizable
to other settings and health systems. Others, such as the
trade-off between moral and legal responsibility, will re-
quire assessment in other health systems. Third, we in-
terviewed only 10 individuals. However, this information
was triangulated with data from documents and observa-
tion of meetings. Finally, our participants may each have
seen the problem from their own "biased" perspective.
We interviewed patients, health care providers, and ad-
ministrators. Unfortunately, government officials de-
clined our requests for an interview, so their perspective
was reflected only through public statements in the me-
dia and in planning documents.
In conclusion, human resource planning plays a critical
role in the causes and solutions of waiting lists. Waiting
lists have harsh implications for patients. Accountability
relationships require realignment.BMC Health Services Research (2001) 1:3 http://www.biomedcentral.com/1472-6963/1/3
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